Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Endonovo Therapeutics's total debt was $38.39K at Dec 31, 2019. For fiscal 2019 it was $38.39K, up 19.8% from the year before. The highest annual figure on record is $51.66K in fiscal 2012.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $38.39K | +19.8% |
| FY2018 | Dec 31, 2018 | $32.05K | +22.3% |
| FY2017 | Dec 31, 2017 | $26.20K | -19.8% |
| FY2016 | Dec 31, 2016 | $32.68K | -17.7% |
| FY2015 | Dec 31, 2015 | $39.69K | -1.6% |
| FY2014 | Dec 31, 2014 | $40.32K | -4.9% |
| FY2013 | Dec 31, 2013 | $42.39K | -17.9% |
| FY2012 | Dec 31, 2012 | $51.66K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $38.39K | +421.9% |
| Q4 FY2018 | Dec 31, 2018 | $32.05K | +206.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.06K | -91.5% |
| Q4 FY2017 | Dec 31, 2017 | $26.20K | -19.8% |
| Q3 FY2017 | Sep 30, 2017 | $7.36K | -99.6% |
| Q2 FY2017 | Jun 30, 2017 | $10.47K | -95.6% |
| Q1 FY2017 | Mar 31, 2017 | $12.49K | -68.5% |
| Q4 FY2016 | Dec 31, 2016 | $32.68K | -12.7% |
| Q3 FY2016 | Sep 30, 2016 | $1.88M | +4558.5% |
| Q1 FY2016 | Jun 30, 2016 | $237.44K | +460.2% |
| Q4 FY2015 | Dec 31, 2015 | $39.69K | -8.1% |
| Q1 FY2015 | Mar 31, 2015 | $37.44K | -31.3% |
| Q4 FY2014 | Dec 31, 2014 | $40.32K | -42.0% |
| Q4 FY2013 | Dec 31, 2013 | $42.39K | – |
| Q3 FY2013 | Sep 30, 2013 | $43.19K | – |
| Q2 FY2013 | Jun 30, 2013 | $54.48K | – |
| Q1 FY2013 | Mar 31, 2013 | $69.54K | – |
See a number that looks wrong?